An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide

NIH RePORTER · NIH · R42 · $480,049 · view on reporter.nih.gov ↗

Abstract

ABSTRACT Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will contribute to our understanding of the use of mobile technology as a suicide prevention tool.

Key facts

NIH application ID
10810681
Project number
6R42MH125691-03
Recipient
OUI THERAPEUTICS, INC
Principal Investigator
Seth Feuerstein
Activity code
R42
Funding institute
NIH
Fiscal year
2024
Award amount
$480,049
Award type
6
Project period
2021-02-15 → 2026-03-31